Hot Pursuit     15-Feb-17
Vivimed Labs in pink of health after strong Q3 result
Vivimed Labs surged 6.91% to Rs 103.70 at 9:51 IST on BSE after consolidated net profit spurted 124.63% to Rs 51.71 crore on 9.13% increase in net sales to Rs 360.03 crore in Q3 December 2016 over Q3 December 2015.
The result was announced after market hours yesterday, 14 February 2017.

Meanwhile, the S&P BSE Sensex was down 21.35 points, or 0.08%, to 28,317.96.

On the BSE, 5.39 lakh shares were traded on the counter so far as against the average daily volumes of 1.49 lakh shares in the past one quarter. The stock had hit a high of Rs 110.50 and a low of Rs 103 so far during the day.

The stock had hit a record high of Rs 121.15 on 4 October 2016 and a 52-week low of Rs 68 on 9 August 2016. The stock had underperformed the market over the past one month till 14 February 2017, declining 4.9% compared with the Sensex's 4.04% rise. The scrip had also underperformed the market over the past one quarter advancing 3.47% as against the Sensex's 5.67% rise.

The small-cap company has equity capital of Rs 16.20 crore. Face value per share is Rs 2.

Vivimed Labs is a niche specialty chemicals and pharmaceuticals company.

Previous News
  Vivimed Labs postpones board meeting
 ( Corporate News - 18-May-24   11:32 )
  Vivimed Labs receives Ukraine GMP approval for Jeedimetla facility
 ( Corporate News - 04-Mar-21   18:38 )
  Vivimed Labs to discuss results
 ( Corporate News - 01-Feb-24   10:55 )
  Vivimed Labs consolidated net profit rises 12.44% in the September 2016 quarter
 ( Results - Announcements 14-Nov-16   15:47 )
  Vivimed Labs reports consolidated net loss of Rs 23.68 crore in the December 2021 quarter
 ( Results - Announcements 15-Feb-22   08:18 )
  Vivimed Labs reports standalone net loss of Rs 23.63 crore in the December 2021 quarter
 ( Results - Announcements 15-Feb-22   08:14 )
  Vivimed Labs to declare Quarterly Result
 ( Corporate News - 20-May-22   16:12 )
  Vivimed Labs soars after Jeedimetla facility gets Ukraine GMP approval
 ( Hot Pursuit - 04-Mar-21   14:00 )
  Vivimed Labs standalone net profit declines 25.55% in the September 2016 quarter
 ( Results - Announcements 14-Nov-16   15:30 )
  Vivimed Labs to discuss results
 ( Corporate News - 29-Jul-23   12:54 )
  Vivimed Labs Ltd Spurts 3.01%
 ( Hot Pursuit - 04-Jul-19   09:30 )
Other Stories
  Zydus Life rises on USFDA nod for heart failure drug
  10-Jul-24   15:36
  Paint stocks jump after price hikes by industry leaders
  10-Jul-24   15:31
  Sportking India spurts as board to mull stock split on 20 July
  10-Jul-24   15:14
  Blue Star Ltd leads losers in 'A' group
  10-Jul-24   15:01
  M&M hit the brakes after XUV700 price cut
  10-Jul-24   14:58
  Shashijit Infraprojects Ltd leads losers in 'B' group
  10-Jul-24   14:46
  Greaves Cotton rises as arm partners with ACKO to facilitate EV ownership in India
  10-Jul-24   14:44
  Lloyd Metals raises Rs 1,218 cr via QIP issue
  10-Jul-24   14:43
  KDDL gains after board grants approval to Rs 88 crore share buyback proposal
  10-Jul-24   14:37
  Volumes spurt at Rajesh Exports Ltd counter
  10-Jul-24   14:31
Back Top